Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

Clinical trial NCT00003747 · UNKNOWN

Trial details

NCT number: NCT00003747
Sponsor: Mount Vernon Cancer Centre at Mount Vernon Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1998-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.